Ocugen to co-develop Covaxin with Bharat Biotech

In a major booster for ‘Make in India’, vaccine maker Bharat Biotech has inked a binding letter of intent (LoI) with US-based biopharmaceutical player Ocugen Inc for co-developing India’s first indigenous Covid-19 vaccine candidate Covaxin for the US market. Source link

Read More

PM set to visit Bharat Biotech in Hyd on Sat

Prime Minister Narendra Modi will be flying into Hyderabad on Saturday to visit vaccine maker Bharat Biotech’s facilities as part of his whirlwind three-city tour. He will take stock of the ongoing Covid-19 vaccine development work in the country during the trip. […]

Read More